Here are the DEF 14A proxy statements from AtaiBeckley Inc. (ATAI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ATAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATAI filings page.
AtaiBeckley Inc. is asking stockholders to vote at its 2026 virtual annual meeting on June 4, 2026. The proxy seeks approval to elect three Class I directors — Sabrina Martucci Johnson, Amir Kalali, M.D., and Andrea Heslin Smiley — to terms ending at the 2029 annual meeting, and to ratify Deloitte & Touche LLP as independent auditor for 2026.
Holders of 366,916,896 common shares outstanding as of April 9, 2026 are entitled to one vote per share and may vote online, by telephone, or by mail. The company highlights its recent strategic combination of atai Life Sciences and Beckley Psytech and redomiciliation to Delaware, a classified nine‑member board, standard Nasdaq-based independence, and policies covering clawbacks, anti‑hedging, insider trading, and related‑party approvals.
The proxy details security ownership, including a 15.0% stake held by Apeiron Investment Group Ltd., board and committee composition, meeting procedures for the fully virtual format, auditor fees, and prior capital raises in 2025 via a public offering and PIPE financing that included significant Apeiron participation.